Table 1.
Baseline clinicopathologic characteristics of breast cancer participants
Feature | No. of patients (%) n=522 |
---|---|
Age group | |
<40 | 69 (13.2) |
40-49 | 144 (27.6) |
50-59 | 188 (35.9) |
60-69 | 86 (16.5) |
≥70 | 35 (6.7) |
Age | |
Young (≤40 Y-O) | 81 (69.8) |
Older (≥70 Y-O) | 35 (30.2) |
Tumor location | |
Right | 234 (44.8) |
Left | 285 (54.6) |
Bilateral | 3 (0.6) |
Tumor size (cm) | |
≤2 | 261 (50.0) |
>2-5 | 242 (46.4) |
>5 | 19 (3.6) |
pTNM stage | |
I | 134 (25.7) |
II | 306 (58.6) |
III | 82 (15.7) |
Risk category | |
Low | 24 (4.6) |
Intermediate | 359 (68.8) |
High | 139 (26.6) |
Outcome | |
Die | 24 (12.3) |
Survival | 171 (87.7) |
Recurrence | |
No Relapse | 192 (98.5) |
Relapse | 3 (1.5) |
Histopathologic type | |
Invasive ductal, NOS | 374 (71.6) |
Mucinous | 16 (3.1) |
Lobular | 89 (17.0) |
Other | 43 (8.2) |
Histologic grade | |
I | 56 (10.7) |
II | 190 (36.4) |
III | 276 (52.9) |
Lymph node status | |
Negative | 330 (63.2) |
1-3 positive node (s) | 121 (23.2) |
>3 positive nodes | 71 (13.6) |
Nottingham PI | |
Good | 122 (23.4) |
Moderate | 281 (53.8) |
Poor | 119 (22.8) |
LVI | |
Negative | 337 (64.6) |
Positive | 185 (35.4) |
Tumor necrosis | |
Negative | 429 (82.2) |
Positive | 93 (17.8) |
Ki67 index | |
Low (≤20%) | 271 (51.9) |
High (>20%) | 251 (48.1) |